APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Rifaximin Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Rifaximin Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174033000327 December 2025197 pages

Choose your research edition.

Industry ResearchRifaximin Tablets Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Rifaximin Tablets Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Rifaximin Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rifaximin Tablets Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Rifaximin Tablets Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Rifaximin Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Rifaximin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rifaximin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rifaximin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Rifaximin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rifaximin Tablets include Aden Healthcare, Alfasigma SpA, AS Lifesciences, Estrellas Life Sciences Private Limited, Gnova Biotech, Healthy Life Pharma Pvt. Ltd., Netprime Pharma, Norgine Limited and Nanchang Feihong Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rifaximin Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rifaximin Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rifaximin Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rifaximin Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Rifaximin Tablets Segment by Company

Aden Healthcare

Alfasigma SpA

AS Lifesciences

Estrellas Life Sciences Private Limited

Gnova Biotech

Healthy Life Pharma Pvt. Ltd.

Netprime Pharma

Norgine Limited

Nanchang Feihong Pharmaceutical Co., Ltd.

Shandong Zibo Xinda Pharmaceutical Co., Ltd.

Shaanxi Kaiyuan Pharmaceutical Co., Ltd.

Shenyang Tonglian Pharmaceutical Co., Ltd.

Sichuan Baili Pharmaceutical Co., Ltd.

Sichuan Mingxing Pharmaceutical Co., Ltd.

Tianjin Junan Biopharmaceutical Co., Ltd.

Chongqing Laimi Pharmaceutical Co., Ltd.

Chongqing Sino Biopharmaceutical Co., Ltd.

Rifaximin Tablets Segment by Type

0.1g

0.2g

Rifaximin Tablets Segment by Application

Clinic

Hospital

Other

Rifaximin Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rifaximin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rifaximin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rifaximin Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rifaximin Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rifaximin Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Rifaximin Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Rifaximin Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Rifaximin Tablets Industry Trends Table 2. Rifaximin Tablets Industry Drivers Table 3. Rifaximin Tablets Industry Opportunities and Challenges Table 4. Rifaximin Tablets Industry Restraints Table 5. Global Rifaximin Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Rifaximin Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Rifaximin Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Rifaximin Tablets Sales Market Share by Manufacturers Table 9. Global Rifaximin Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Rifaximin Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Rifaximin Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Rifaximin Tablets Manufacturers, Product Type & Application Table 13. Global Rifaximin Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Rifaximin Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 0.1g Table 17. Major Manufacturers of 0.2g Table 18. Global Rifaximin Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Rifaximin Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Rifaximin Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Rifaximin Tablets Sales Market Share by Type (2021-2026) Table 22. Global Rifaximin Tablets Sales Market Share by Type (2027-2032) Table 23. Global Rifaximin Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Rifaximin Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Rifaximin Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Rifaximin Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Rifaximin Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Clinic Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Other Table 31. Global Rifaximin Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Rifaximin Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Rifaximin Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Rifaximin Tablets Sales Market Share by Application (2021-2026) Table 35. Global Rifaximin Tablets Sales Market Share by Application (2027-2032) Table 36. Global Rifaximin Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Rifaximin Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Rifaximin Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Rifaximin Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Rifaximin Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Rifaximin Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Rifaximin Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Rifaximin Tablets Sales Market Share by Region (2021-2026) Table 44. Global Rifaximin Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Rifaximin Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Rifaximin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Rifaximin Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Rifaximin Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Rifaximin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Rifaximin Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Rifaximin Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Rifaximin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Rifaximin Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Rifaximin Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Rifaximin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Rifaximin Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Rifaximin Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Rifaximin Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Rifaximin Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Rifaximin Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Rifaximin Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Rifaximin Tablets Revenue Market Share by Region (2027-2032) Table 63. Aden Healthcare Company Information Table 64. Aden Healthcare Business Overview Table 65. Aden Healthcare Rifaximin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Aden Healthcare Rifaximin Tablets Product Portfolio Table 67. Aden Healthcare Recent Development Table 68. Alfasigma SpA Company Information Table 69. Alfasigma SpA Business Overview Table 70. Alfasigma SpA Rifaximin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Alfasigma SpA Rifaximin Tablets Product Portfolio Table 72. Alfasigma SpA Recent Development Table 73. AS Lifesciences Company Information Table 74. AS Lifesciences Business Overview Table 75. AS Lifesciences Rifaximin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. AS Lifesciences Rifaximin Tablets Product Portfolio Table 77. AS Lifesciences Recent Development Table 78. Estrellas Life Sciences Private Limited Company Information Table 79. Estrellas Life Sciences Private Limited Business Overview Table 80. Estrellas Life Sciences Private Limited Rifaximin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Estrellas Life Sciences Private Limited Rifaximin Tablets Product Portfolio Table 82. Estrellas Life Sciences Private Limited Recent Development Table 83. Gnova Biotech Company Information Table 84. Gnova Biotech Business Overview Table 85. Gnova Biotech Rifaximin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Gnova Biotech Rifaximin Tablets Product Portfolio Table 87. Gnova Biotech Recent Development Table 88. Healthy Life Pharma Pvt. Ltd. Company Information Table 89. Healthy Life Pharma Pvt. Ltd. Business Overview Table 90. Healthy Life Pharma Pvt. Ltd. Rifaximin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Healthy Life Pharma Pvt. Ltd. Rifaximin Tablets Product Portfolio Table 92. Healthy Life Pharma Pvt. Ltd. Recent Development Table 93. Netprime Pharma Company Information Table 94. Netprime Pharma Business Overview Table 95. Netprime Pharma Rifaximin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Netprime Pharma Rifaximin Tablets Product Portfolio Table 97. Netprime Pharma Recent Development Table 98. Norgine Limited Company Information Table 99. Norgine Limited Business Overview Table 100. Norgine Limited Rifaximin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Norgine Limited Rifaximin Tablets Product Portfolio Table 102. Norgine Limited Recent Development Table 103. Nanchang Feihong Pharmaceutical Co., Ltd. Company Information Table 104. Nanchang Feihong Pharmaceutical Co., Ltd. Business Overview Table 105. Nanchang Feihong Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Nanchang Feihong Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 107. Nanchang Feihong Pharmaceutical Co., Ltd. Recent Development Table 108. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Company Information Table 109. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Business Overview Table 110. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 112. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Recent Development Table 113. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Company Information Table 114. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Business Overview Table 115. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 117. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Recent Development Table 118. Shenyang Tonglian Pharmaceutical Co., Ltd. Company Information Table 119. Shenyang Tonglian Pharmaceutical Co., Ltd. Business Overview Table 120. Shenyang Tonglian Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Shenyang Tonglian Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 122. Shenyang Tonglian Pharmaceutical Co., Ltd. Recent Development Table 123. Sichuan Baili Pharmaceutical Co., Ltd. Company Information Table 124. Sichuan Baili Pharmaceutical Co., Ltd. Business Overview Table 125. Sichuan Baili Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Sichuan Baili Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 127. Sichuan Baili Pharmaceutical Co., Ltd. Recent Development Table 128. Sichuan Mingxing Pharmaceutical Co., Ltd. Company Information Table 129. Sichuan Mingxing Pharmaceutical Co., Ltd. Business Overview Table 130. Sichuan Mingxing Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Sichuan Mingxing Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 132. Sichuan Mingxing Pharmaceutical Co., Ltd. Recent Development Table 133. Tianjin Junan Biopharmaceutical Co., Ltd. Company Information Table 134. Tianjin Junan Biopharmaceutical Co., Ltd. Business Overview Table 135. Tianjin Junan Biopharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Tianjin Junan Biopharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 137. Tianjin Junan Biopharmaceutical Co., Ltd. Recent Development Table 138. Chongqing Laimi Pharmaceutical Co., Ltd. Company Information Table 139. Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview Table 140. Chongqing Laimi Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Chongqing Laimi Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 142. Chongqing Laimi Pharmaceutical Co., Ltd. Recent Development Table 143. Chongqing Sino Biopharmaceutical Co., Ltd. Company Information Table 144. Chongqing Sino Biopharmaceutical Co., Ltd. Business Overview Table 145. Chongqing Sino Biopharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Chongqing Sino Biopharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 147. Chongqing Sino Biopharmaceutical Co., Ltd. Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Rifaximin Tablets Distributors List Table 151. Rifaximin Tablets Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Rifaximin Tablets Product Image Figure 2. Global Rifaximin Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rifaximin Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Rifaximin Tablets Sales (2021-2032) & (K Units) Figure 5. Global Rifaximin Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Rifaximin Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 0.1g Image Figure 9. 0.2g Image Figure 10. Global Rifaximin Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Rifaximin Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Rifaximin Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Rifaximin Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Rifaximin Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Rifaximin Tablets Revenue Market Share by Type (2021-2032) Figure 16. Clinic Image Figure 17. Hospital Image Figure 18. Other Image Figure 19. Global Rifaximin Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Rifaximin Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Rifaximin Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Rifaximin Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Rifaximin Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Rifaximin Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Rifaximin Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Rifaximin Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Rifaximin Tablets Sales Market Share by Country (2021-2032) Figure 39. China Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Rifaximin Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Rifaximin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Rifaximin Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Rifaximin Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Rifaximin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Rifaximin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Rifaximin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Rifaximin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Rifaximin Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Rifaximin Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 0.1g
  • 0.2g
Applications
  • Clinic
  • Hospital
  • Other
Companies covered
  • Aden Healthcare
  • Alfasigma SpA
  • AS Lifesciences
  • Estrellas Life Sciences Private Limited
  • Gnova Biotech
  • Healthy Life Pharma Pvt. Ltd.
  • Netprime Pharma
  • Norgine Limited
  • Nanchang Feihong Pharmaceutical Co., Ltd.
  • Shandong Zibo Xinda Pharmaceutical Co., Ltd.
  • Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
  • Shenyang Tonglian Pharmaceutical Co., Ltd.
  • Sichuan Baili Pharmaceutical Co., Ltd.
  • Sichuan Mingxing Pharmaceutical Co., Ltd.
  • Tianjin Junan Biopharmaceutical Co., Ltd.
  • Chongqing Laimi Pharmaceutical Co., Ltd.
  • Chongqing Sino Biopharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Rifaximin Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Rifaximin Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Rifaximin Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Rifaximin Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Rifaximin Tablets Market Dynamics
  1. 2.1 Rifaximin Tablets Industry Trends
  2. 2.2 Rifaximin Tablets Industry Drivers
  3. 2.3 Rifaximin Tablets Industry Opportunities and Challenges
  4. 2.4 Rifaximin Tablets Industry Restraints
3 Rifaximin Tablets Market by Manufacturers
  1. 3.1 Global Rifaximin Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Rifaximin Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Rifaximin Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Rifaximin Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rifaximin Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Rifaximin Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Rifaximin Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rifaximin Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rifaximin Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rifaximin Tablets Tier 1, Tier 2, and Tier 3
4 Rifaximin Tablets Market by Type
  1. 4.1 Rifaximin Tablets Type Introduction
  2. 4.1.1 0.1g
  3. 4.1.2 0.2g
  4. 4.2 Global Rifaximin Tablets Sales by Type
  5. 4.2.1 Global Rifaximin Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Rifaximin Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Rifaximin Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Rifaximin Tablets Revenue by Type
  9. 4.3.1 Global Rifaximin Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Rifaximin Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Rifaximin Tablets Revenue Market Share by Type (2021-2032)
5 Rifaximin Tablets Market by Application
  1. 5.1 Rifaximin Tablets Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Other
  5. 5.2 Global Rifaximin Tablets Sales by Application
  6. 5.2.1 Global Rifaximin Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rifaximin Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Rifaximin Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Rifaximin Tablets Revenue by Application
  10. 5.3.1 Global Rifaximin Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Rifaximin Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Rifaximin Tablets Revenue Market Share by Application (2021-2032)
6 Global Rifaximin Tablets Sales by Region
  1. 6.1 Global Rifaximin Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rifaximin Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Rifaximin Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Rifaximin Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Rifaximin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Rifaximin Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Rifaximin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Rifaximin Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Rifaximin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Rifaximin Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Rifaximin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Rifaximin Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Rifaximin Tablets Revenue by Region
  1. 7.1 Global Rifaximin Tablets Revenue by Region
  2. 7.1.1 Global Rifaximin Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Rifaximin Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Rifaximin Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Rifaximin Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Rifaximin Tablets Revenue (2021-2032)
  8. 7.2.2 North America Rifaximin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Rifaximin Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Rifaximin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Rifaximin Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Rifaximin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Rifaximin Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Rifaximin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aden Healthcare
  2. 8.1.1 Aden Healthcare Company Information
  3. 8.1.2 Aden Healthcare Business Overview
  4. 8.1.3 Aden Healthcare Rifaximin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aden Healthcare Rifaximin Tablets Product Portfolio
  6. 8.1.5 Aden Healthcare Recent Developments
  7. 8.2 Alfasigma SpA
  8. 8.2.1 Alfasigma SpA Company Information
  9. 8.2.2 Alfasigma SpA Business Overview
  10. 8.2.3 Alfasigma SpA Rifaximin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Alfasigma SpA Rifaximin Tablets Product Portfolio
  12. 8.2.5 Alfasigma SpA Recent Developments
  13. 8.3 AS Lifesciences
  14. 8.3.1 AS Lifesciences Company Information
  15. 8.3.2 AS Lifesciences Business Overview
  16. 8.3.3 AS Lifesciences Rifaximin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AS Lifesciences Rifaximin Tablets Product Portfolio
  18. 8.3.5 AS Lifesciences Recent Developments
  19. 8.4 Estrellas Life Sciences Private Limited
  20. 8.4.1 Estrellas Life Sciences Private Limited Company Information
  21. 8.4.2 Estrellas Life Sciences Private Limited Business Overview
  22. 8.4.3 Estrellas Life Sciences Private Limited Rifaximin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Estrellas Life Sciences Private Limited Rifaximin Tablets Product Portfolio
  24. 8.4.5 Estrellas Life Sciences Private Limited Recent Developments
  25. 8.5 Gnova Biotech
  26. 8.5.1 Gnova Biotech Company Information
  27. 8.5.2 Gnova Biotech Business Overview
  28. 8.5.3 Gnova Biotech Rifaximin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Gnova Biotech Rifaximin Tablets Product Portfolio
  30. 8.5.5 Gnova Biotech Recent Developments
  31. 8.6 Healthy Life Pharma Pvt. Ltd.
  32. 8.6.1 Healthy Life Pharma Pvt. Ltd. Company Information
  33. 8.6.2 Healthy Life Pharma Pvt. Ltd. Business Overview
  34. 8.6.3 Healthy Life Pharma Pvt. Ltd. Rifaximin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Healthy Life Pharma Pvt. Ltd. Rifaximin Tablets Product Portfolio
  36. 8.6.5 Healthy Life Pharma Pvt. Ltd. Recent Developments
  37. 8.7 Netprime Pharma
  38. 8.7.1 Netprime Pharma Company Information
  39. 8.7.2 Netprime Pharma Business Overview
  40. 8.7.3 Netprime Pharma Rifaximin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Netprime Pharma Rifaximin Tablets Product Portfolio
  42. 8.7.5 Netprime Pharma Recent Developments
  43. 8.8 Norgine Limited
  44. 8.8.1 Norgine Limited Company Information
  45. 8.8.2 Norgine Limited Business Overview
  46. 8.8.3 Norgine Limited Rifaximin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Norgine Limited Rifaximin Tablets Product Portfolio
  48. 8.8.5 Norgine Limited Recent Developments
  49. 8.9 Nanchang Feihong Pharmaceutical Co., Ltd.
  50. 8.9.1 Nanchang Feihong Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Nanchang Feihong Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Nanchang Feihong Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Nanchang Feihong Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  54. 8.9.5 Nanchang Feihong Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Shandong Zibo Xinda Pharmaceutical Co., Ltd.
  56. 8.10.1 Shandong Zibo Xinda Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Shandong Zibo Xinda Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Shandong Zibo Xinda Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shandong Zibo Xinda Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  60. 8.10.5 Shandong Zibo Xinda Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
  62. 8.11.1 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  66. 8.11.5 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Shenyang Tonglian Pharmaceutical Co., Ltd.
  68. 8.12.1 Shenyang Tonglian Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Shenyang Tonglian Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Shenyang Tonglian Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shenyang Tonglian Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  72. 8.12.5 Shenyang Tonglian Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Sichuan Baili Pharmaceutical Co., Ltd.
  74. 8.13.1 Sichuan Baili Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Sichuan Baili Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Sichuan Baili Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sichuan Baili Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  78. 8.13.5 Sichuan Baili Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Sichuan Mingxing Pharmaceutical Co., Ltd.
  80. 8.14.1 Sichuan Mingxing Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Sichuan Mingxing Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Sichuan Mingxing Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sichuan Mingxing Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  84. 8.14.5 Sichuan Mingxing Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Tianjin Junan Biopharmaceutical Co., Ltd.
  86. 8.15.1 Tianjin Junan Biopharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Tianjin Junan Biopharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Tianjin Junan Biopharmaceutical Co., Ltd. Rifaximin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Tianjin Junan Biopharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  90. 8.15.5 Tianjin Junan Biopharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Chongqing Laimi Pharmaceutical Co., Ltd.
  92. 8.16.1 Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Chongqing Laimi Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Chongqing Laimi Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  96. 8.16.5 Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Chongqing Sino Biopharmaceutical Co., Ltd.
  98. 8.17.1 Chongqing Sino Biopharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Chongqing Sino Biopharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Chongqing Sino Biopharmaceutical Co., Ltd. Rifaximin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Chongqing Sino Biopharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  102. 8.17.5 Chongqing Sino Biopharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rifaximin Tablets Value Chain Analysis
  2. 9.1.1 Rifaximin Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rifaximin Tablets Production Mode & Process
  6. 9.2 Rifaximin Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rifaximin Tablets Distributors
  9. 9.2.3 Rifaximin Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst